Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2017 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for hendrik rankl
Your search for Hendrik Rackl retrieved no results
Expression of RANK-ligand in prostate cancer cell lines.
Penno H, Nilsson O, Brändström H, Winqvist O, Ljunggren O. Penno H, et al. Scand J Clin Lab Invest. 2009;69(1):151-5. doi: 10.1080/00365510802460466. Scand J Clin Lab Invest. 2009. PMID: 19058084
RANKL is a potent stimulator of osteoclastic bone resorption and is expressed in a variety of tumour cells. ...Three prostate cancer cell lines were co-cultured with human osteoblast-like cells (hOB) and RANKL expression on cell surface was measured by FACS. We foun …
RANKL is a potent stimulator of osteoclastic bone resorption and is expressed in a variety of tumour cells. ...Three prostate cancer …
Ferryl Hemoglobin Inhibits Osteoclastic Differentiation of Macrophages in Hemorrhaged Atherosclerotic Plaques.
Zavaczki E, Gáll T, Zarjou A, Hendrik Z, Potor L, Tóth CZ, Méhes G, Gyetvai Á, Agarwal A, Balla G, Balla J. Zavaczki E, et al. Oxid Med Cell Longev. 2020 Feb 27;2020:3721383. doi: 10.1155/2020/3721383. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32184915 Free PMC article.
FHb, but not ferrohemoglobin, decreased bone resorption activity and inhibited osteoclast-specific gene expression (tartrate-resistant acid phosphatase, calcitonin receptor, and dendritic cell-specific transmembrane protein) induced by RANKL. In addition, FHb inhibited ost …
FHb, but not ferrohemoglobin, decreased bone resorption activity and inhibited osteoclast-specific gene expression (tartrate-resistant acid …
Emerging novel therapies for advanced prostate cancer.
Osanto S, Van Poppel H. Osanto S, et al. Ther Adv Urol. 2012 Feb;4(1):3-12. doi: 10.1177/1756287211432777. Ther Adv Urol. 2012. PMID: 22295041 Free PMC article.
A new bone-targeting agent, denosumab, a receptor activator of nuclear factor kappaB ligand (RANKL) antagonist, showed a modest reduction in SREs in comparison to zoledronic acid in patients with bone metastases. ...
A new bone-targeting agent, denosumab, a receptor activator of nuclear factor kappaB ligand (RANKL) antagonist, showed a modest reduc …
RANK-ligand and osteoprotegerin as biomarkers in the differentiation between periprosthetic joint infection and aseptic prosthesis loosening.
Friedrich MJ, Wimmer MD, Schmolders J, Strauss AC, Ploeger MM, Kohlhof H, Wirtz DC, Gravius S, Randau TM. Friedrich MJ, et al. World J Orthop. 2017 Apr 18;8(4):342-349. doi: 10.5312/wjo.v8.i4.342. eCollection 2017 Apr 18. World J Orthop. 2017. PMID: 28473963 Free PMC article.
No statistically significant differences in the serum concentration of RANKL (P = 0.16) and OPG (P = 0.45) were found between aseptic loosening and PJI, with a trend towards lower RANKL concentrations and higher OPG concentrations in the PJI group. The RANKL/ …
No statistically significant differences in the serum concentration of RANKL (P = 0.16) and OPG (P = 0.45) were found between aseptic …